A
Anat Mirelman
Researcher at Tel Aviv Sourasky Medical Center
Publications - 246
Citations - 12440
Anat Mirelman is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Medicine & Gait (human). The author has an hindex of 47, co-authored 208 publications receiving 9246 citations. Previous affiliations of Anat Mirelman include Harvard University & Ben-Gurion University of the Negev.
Papers
More filters
Journal ArticleDOI
The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
Noa Bregman,Tamara Shiner,Gitit Kavé,Roy N. Alcalay,Mali Gana-Weisz,Orly Goldstein,Tal Glinka,Orna Aizenstein,Dafna Ben Bashat,Yifat Alcalay,Anat Mirelman,Avner Thaler,Nir Giladi,Nurit Omer +13 more
TL;DR: In this article , the authors presented the protocol of a cross-sectional and longitudinal natural history study of Creutzfeldt-Jakob Disease (CJD) patients and first-degree relatives of gCJD patients, aiming to identify biological markers of preclinical CJD and risk factors for phenoconversion.
Journal ArticleDOI
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
Eva-Juliane Vollstedt,Susen Schaake,Katja Lohmann,K. Padmanabhan,Alexis Brice,Suzanne Lesage,Christelle Tesson,Marie Vidailhet,Isabel Wurster,Fayçal Hentati,Anat Mirelman,Nir Giladi,Karen Marder,Cheryl Waters,Stanley Fahn,Meike Kasten,Norbert Brüggemann,Max Borsche,Tatiana Foroud,Eduardo Tolosa,Alicia Garrido,Grazia Annesi,Monica Gagliardi,Maria Bozi,Leonidas Stefanis,Joaquim J. Ferreira,Leonor Correia Guedes,Micol Avenali,Simona Petrucci,Lorraine N. Clark,Ekaterina Yu. Fedotova,N.Y. Abramycheva,Victoria Alvarez,Manuel Menéndez-González,Silvia Jesús Maestre,Pilar Gómez-Garre,Pablo Mir,Andrea Carmine Belin,Caroline Ran,Chin-Hsien Lin,Ming-Che Kuo,David Crosiers,Zbigniew K. Wszolek,Owen A. Ross,Joseph Jankovic,Kenya Nishioka,Manabu Funayama,Jordi Clarimón,Caroline H. Williams-Gray,Marta Camacho,Mario Cornejo-Olivas,Luis Torres-Ramírez,Yih Ru Wu,G. J. Lee-Chen,Ana Morgadinho,Teeratorn Pulkes,Pichet Termsarasab,Daniela Berg,Gregor Kuhlenbäumer,Andrea A. Kühn,Friederike Borngräber,G. De Michele,A. De Rosa,Alexander Zimprich,Andreas Puschmann,George D. Mellick,Jolanta Dorszewska,Jonathan Carr,Rosangela Ferese,Stefano Gambardella,Bruce A. Chase,Katerina Markopoulou,Wataru Satake,Tatsushi Toda,Marco Rossi,Marcelo Merello,Timothy Lynch,Diana A. Olszewska,Shen-Yang Lim,Azlina Ahmad-Annuar,Ai Huey Tan,Bashayer M. Al-Mubarak,Hasmet Hanagasi,Dariusz Koziorowski,Sibel Ertan,Gençer Genç,Patricia de Carvalho Aguiar,Melinda Barkhuizen,Márcia Mattos Gonçalves Pimentel,Rachel Saunders-Pullman,Bart van de Warrenburg,Susan B. Bressman,Mathias Toft,Silke Appel-Cresswell,Anthony E. Lang,Matej Skorvanek,Agnita J.W. Boon,Rejko Krüger,Esther Sammler,Vitor Tumas,Baorong Zhang,Gaëtan Garraux,Sun Ju Chung,Yun Joong Kim,Juliane Winkelmann,Carolyn M. Sue,Eng-King Tan,Joana Damásio,Péter Klivényi,Vladimir S. Kostic,David Arkadir,Mika H. Martikainen,Vanderci Borges,Jens Michael Hertz,Laura Brighina,Mariana Spitz,Oksana Suchowersky,Olaf Riess,Parimal Das,Brit Mollenhauer,Emilia Gatto,Maria Skaalum Petersen,Nobutaka Hattori,Ruey-Meei Wu,Sergey N. Illarioshkin,Enza Maria Valente,Jan O. Aasly,Anna Aasly,Roy N. Alcalay,Avner Thaler,Matthew J. Farrer,Kathrin Brockmann,Jean-Christophe Corvol,Christine Klein +133 more
TL;DR: In this paper , a small fraction of the estimated number of subjects with monogenic PD worldwide are currently represented in the literature and availability of clinical data and clinical trial-ready cohorts is limited.
Journal ArticleDOI
Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant
Rachel Saunders-Pullman,Roberto A. Ortega,Cuiling Wang,Deborah Raymond,Sonya Elango,K. Leaver,Nikita Urval,Viktoriya Katsnelson,Rachel Gerber,Matthew Swan,Vicki Shanker,Roy N. Alcalay,Anat Mirelman,Michael C. Brumm,Helen Mejia-Santana,Christopher S. Coffey,Kenneth Marek,Laurie J. Ozelius,Nir Giladi,Karen Marder,Susan B. Bressman +20 more
TL;DR: Class II evidence is provided that worse olfactory scores were associated with an earlier age-at-symptomatic onset and faster rate of motor deterioration in patients with LRRK2 PD, and shows that the worst olfaction group has earlier age at PD onset, and more rapid motor decline.
Journal ArticleDOI
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity
Nurit Omer,Nir Giladi,Tanya Gurevich,Anat Bar-Shira,Mali Gana-Weisz,Tal Glinka,Orly Goldstein,Meir Kestenbaum,Jesse M. Cedarbaum,Omar S. Mabrouk,Kyle B. Fraser,Julia Shirvan,Avi Orr-Urtreger,Anat Mirelman,Avner Thaler +14 more
TL;DR: It is clear that a relationship between GBA1-encoded lysosomal glucocerebrosidase activity and PD risk and progression cannot be discerned by an assay that measures cell-free, resuspended, and enhanced glu cocerebosidase.